Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | HLX60 |
Trade Name | |
Synonyms | HLX-60|HLX 60 |
Drug Descriptions |
HLX60 is a monoclonal antibody that targets the TGFbeta activator GARP (LRRC32), preventing the release of TGFbeta1, which potentially results in increased antitumor response (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C189812 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
HLX60 | HLX60 | 0 | 0 |
HLX60 + Serplulimab | HLX60 Serplulimab | 0 | 1 |